Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Reexamination Certificate
2007-06-26
2007-06-26
Balasubramanian, Venkataraman (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
C514S242000
Reexamination Certificate
active
11167828
ABSTRACT:
The present invention relates to the methods for preparing compounds of the formula I:or the pharmaceutically acceptable salts thereof, wherein R1, R2, R4, R10, and R11have any of the values defined in the specification. The compounds of the present invention are useful in the treatment of diseases, including inflammatory diseases such as rheumatoid arthritis.
REFERENCES:
patent: 4318731 (1982-03-01), Kajioka et al.
patent: 4594099 (1986-06-01), Yamada et al.
patent: 4766233 (1988-08-01), Lyga
patent: 4806145 (1989-02-01), Maravetz
patent: 4906286 (1990-03-01), Lyga
patent: 4906287 (1990-03-01), Lyga et al.
patent: 4909833 (1990-03-01), Kajioka et al.
patent: 5017211 (1991-05-01), Wenger et al.
patent: 5077409 (1991-12-01), Wissner
patent: 5128351 (1992-07-01), Wissner
patent: 5281614 (1994-01-01), Ashton et al.
patent: 5411980 (1995-05-01), Ashton et al.
patent: 5686061 (1997-11-01), Li et al.
patent: 5773646 (1998-06-01), Chandrakumar et al.
patent: 5939418 (1999-08-01), Quan et al.
patent: 5948803 (1999-09-01), Maeda et al.
patent: 5961376 (1999-10-01), Gottschald
patent: 6001862 (1999-12-01), Maeda et al.
patent: 6020357 (2000-02-01), Pinto et al.
patent: 6030990 (2000-02-01), Maeda et al.
patent: 6147101 (2000-11-01), Maeda et al.
patent: 6180844 (2001-01-01), Fujita et al.
patent: 6187797 (2001-02-01), Pruitt et al.
patent: 6201024 (2001-03-01), Baxter et al.
patent: 6201130 (2001-03-01), Schwab et al.
patent: 6218376 (2001-04-01), Kindon et al.
patent: 6242470 (2001-06-01), Baxter et al.
patent: 6258838 (2001-07-01), Baxter et al.
patent: 6265409 (2001-07-01), Cheshire et al.
patent: 6297239 (2001-10-01), deSolms et al.
patent: 6303659 (2001-10-01), Baxter et al.
patent: 6320078 (2001-11-01), Suzuki et al.
patent: 6335333 (2002-01-01), Schwab et al.
patent: 6451824 (2002-09-01), Thorwart et al.
patent: 6492355 (2002-12-01), Alcaraz et al.
patent: 6534492 (2003-03-01), Carlsen et al.
patent: 6555541 (2003-04-01), Furber et al.
patent: 6653312 (2003-11-01), Auvin et al.
patent: 6720452 (2004-04-01), Alcaraz et al.
patent: 6927219 (2005-08-01), Duplantier
patent: 6974812 (2005-12-01), Dombroski et al.
patent: 2003/0013704 (2003-01-01), Alcaraz et al.
patent: 2003/0013721 (2003-01-01), Meghani et al.
patent: 2003/0032807 (2003-02-01), Andree et al.
patent: 2003/0040513 (2003-02-01), Baxter et al.
patent: 2003/0186981 (2003-10-01), Duplantier et al.
patent: 2004/0072876 (2004-04-01), Kuroda et al.
patent: 2004/0180894 (2004-09-01), Dombroski et al.
patent: 2005/0009900 (2005-01-01), Dombroski et al.
patent: 0 077 938 (1983-05-01), None
patent: 0 138 527 (1985-04-01), None
patent: 0 514 339 (1992-11-01), None
patent: 0 563 384 (1993-10-01), None
patent: 0 688 773 (1995-12-01), None
patent: WO 86/00072 (1986-01-01), None
patent: WO 92/11242 (1992-07-01), None
patent: WO 93/04686 (1993-03-01), None
patent: WO 95/22532 (1995-08-01), None
patent: WO 96/01254 (1996-01-01), None
patent: WO 98/28269 (1998-07-01), None
patent: WO 99/29686 (1999-06-01), None
patent: WO 00/35864 (2000-06-01), None
patent: WO 00/71509 (2000-11-01), None
patent: WO 01/23378 (2001-04-01), None
patent: WO 01/28498 (2001-04-01), None
patent: WO 2004/058270 (2004-07-01), None
patent: WO 2004/058731 (2004-07-01), None
U.S. Appl. No. 11/168,602, filed Jun. 28, 2005, Chung et al.
U.S. Appl. No. 11/167,786, filed Jun. 27, 2005, Leonard et al.
U.S. Appl. No. 10/748,342, filed Dec. 30, 2003, Dombroski et al.
Theodoridis et al., “Synthesis and Structure-Activity Relationships of 1-Aryl-4-substituted-1,4-dihydro-5H-tetrazol-5-ones, a Novel Class of Pre- and Post-emergence Herbicides”, Pestic. Sci., 1990, vol. 30, pp. 259-274.
Theodoridis et al., “Synthesis and Herbicidal Properties of Aryltriazolinones”, American Chemical Society, 1992, Chapter 14, pp. 134-146.
Lyga et al., “Synthesis, Herbicidal Activity, and Action Mechanism of 2-Aryl-1,2,4-triazine-3,5-diones”, American Chemical Society, 1991, Chapter 14, pp. 170-181.
Dowd et al., “P2X receptor-mediated excitation of nociceptive afferents in the normal and arthritic rat knee joint”, British Journal of Pharmacology, vol. 125, No. 2, 1998, pp. 341-346.
Chang et al., “Potent and Orally Active Angiotensin II Receptor Antagonists with Equal Affinity for Human AT1 and AT2 Subtypes”, J. Med. Chem., vol. 38, No. 19, 1995, pp. 3741-3758.
Chang et al., “Triazolinone Biphenylsulfonamides as Angiotensin II Receptor Antagonists with High Affinity for Both the AT1 and AT2 Subtypes”, J. Med. Chem., vol. 37, No. 26, 1994, pp. 4464-4478.
Baxter et al., “Hit-to-Lead Studies: The Discovery of Potent Adamantane Amide P2X7 Receptor Antagonists”, Bioorg. Med. Chem. Lett., vol. 13, No. 22, 2003, pp. 4047-4050.
Baraldi et al., “Synthesis and Biological Activity of N-Arylpiperazine-Modified Analogues of KN-62, a Potent Antagonist of the Purinergic P2X7 Receptor”, J. Med. Chem., vol. 46, No. 8, 2003, pp. 1318-1329.
Chang et al., “Triazolinones as Nonpeptide Angiotensin II Antagonists. 1. Synthesis and Evaluation of Potent 2,4,5-Trisubstituted Triazolinones”, J. Med. Chem., vol. 36, No. 17, 1993, pp. 2558-2568.
Bowers et al., “Pharmacological Analysis of the P2Z-Purinoceptor Present on THP-1 Cells”, Drug Development Research, vol. 37, No. 3, 1996, p. 126.
PCT International Search Report, PCT/IB2005/002036.
Ashbrook Charles W.
Balasubramanian Venkataraman
Crissey Todd M.
Eck Steven R.
Pfizer Inc.
LandOfFree
Methods for preparing P2X 7 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for preparing P2X 7 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for preparing P2X 7 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3863628